🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is: * To assess the effect of BIA 5 1058 400 mg ...
Status
Completed
Location
Simbec Research Ltd (Simbec)
Start Date
2018-06-11
Trial ID
NCT07173738
Treatments Being Tested
The purpose of this study is: * To investigate CYP2C9 inhibition by BIA 5-...
Status
Completed
Location
PAREXEL International - Early Phase Clinical Unit - Berlin
Start Date
2018-02-23
Trial ID
NCT04994119
Treatments Being Tested
the purpose of this study is: * To assess the effect of BIA 5 1058 400 mg ...
Status
Completed
Location
PAREXEL International - Early Phase Clinical Unit - Berlin
Start Date
2018-02-06
Trial ID
NCT04991207
Treatments Being Tested
The purpose is to evaluate the effect of single therapeutic (400 mg) and su...
Status
Completed
Location
Covance Clinical Research Unit Ltd.
Start Date
2018-04-09
Trial ID
NCT03489005
Treatments Being Tested
The aim of this study is to investigate the effect of food on the pharmacok...
Status
Completed
Location
Multiple Locations
Start Date
2015-07-20
Trial ID
NCT04991155
Treatments Being Tested
This is a single centre, double-blind, randomised, placebo-controlled, para...
Status
Completed
Location
Quotient Sciences
Start Date
2018-05-28
Trial ID
NCT03708146
Treatments Being Tested
This study aims to assess the safety and tolerability of the individual hig...
Status
Completed
Location
Ordensklinikum Linz Elisabethinen, Interne 2 - Kardiologie, Angiologie & Interne Intensivmedizin Fadingerstraße 1
Start Date
2019-06-26
Trial ID
NCT06009185
Treatments Being Tested
The purpose of this study is to assess the effect of BIA 5-1058 200 mg on t...
Status
Completed
Location
PAREXEL International - Early Phase Clinical Unit
Start Date
2018-02-28
Trial ID
NCT04675944
Treatments Being Tested
The purpose of this study is: * To assess the effect of BIA 5 1058 400 mg ...
Status
Completed
Location
PAREXEL International - Early Phase Clinical Unit - Berlin
Start Date
2018-03-22
Trial ID
NCT04994860
Treatments Being Tested
This Study evaluates the pharmacokinetic (PK) profile of different zamicast...
Status
Completed
Location
Ordensklinikum Linz Elisabethinen, Interne 2 - Kardiologie, Angiologie & Interne Intensivmedizin Fadingerstraße 1
Start Date
2019-06-03
Trial ID
NCT04316143
Treatments Being Tested